Home > Share Market > Stocks > Glaxosmithkline pharmaceuticals > Financial Statements > GLAXO Key Financial Ratios

Glaxosmithkline pharmaceuticals Financial Statements

Glaxosmithkline pharmaceuticals Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2017
Growth matrix (%)        
Revenue growth 12 (9.30) 10.90 2.49
Op profit growth 27.40 (9) 56.90 (12)
EBIT growth 22.10 (3.60) 40.30 (19)
Net profit growth 373 284 (72) (10)
Profitability ratios (%)        
OPM 23.20 20.40 20.40 14.40
EBIT margin 23.50 21.50 20.30 16
Net profit margin 51.70 12.20 2.89 11.60
RoCE 36.90 37.80 33.90 22.10
RoNW 20.50 5.43 1.22 4.02
RoA 20.30 5.37 1.21 3.99
Per share ratios ()        
EPS 100 21.10 5.50 39.80
Dividend per share 90 30 40 30
Cash EPS 96 16.50 0.62 36.70
Book value per share 157 87.30 107 237
Valuation ratios        
P/E 16.60 68.10 226 34.40
P/CEPS 17.30 87.30 2,004 37.30
P/B 10.60 16.50 11.60 5.77
EV/EBIDTA 30.70 32.80 27.20 45.30
Payout (%)        
Dividend payout -- -- -- 75.40
Tax payout (52) (27) (33) (37)
Liquidity ratios        
Debtor days 23.40 19.70 15.30 18.70
Inventory days 60.20 64.20 51.40 59.70
Creditor days (75) (67) (64) (68)
Leverage ratios        
Interest coverage (385) (178) (103) (1,863)
Net debt / equity (0.90) (0.80) (0.60) (0.40)
Net debt / op. profit (3.30) (1.90) (1.60) (2.10)
Cost breakup ()        
Material costs (41) (43) (41) (48)
Employee costs (19) (21) (19) (17)
Other costs (17) (16) (20) (21)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000